• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT SECTIONS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • VIDEOS

Congress Cuts Revenue in Consensus.When Votes Don’t Count

March 26, 2013 By SPINEMarketGroup

The U.S. Senate has voted 79-20, a margin unusual in a closely divided chamber, to support repeal of a 2.3 percent tax on medical devices, one of the measures that helps finance President Barack Obama’s health-care law.Yet even bipartisan support offers little chance of repealing the tax soon.As Obama and Congress start examining taxes and tax exemptions for possible revisions as part of a broader move to ease the federal budget deficit, lawmakers say they are unlikely to act on individual taxes until they agree on a more comprehensive approach to taxation and spending.
“It sets the stage for some negotiations on it in the future,” said Senator Amy Klobuchar, a Democrat and leading opponent of the medical device tax whose state of Minnesota is home to device companies such as Medtronic Inc. (MDT)
The Senate’s March 21 vote was a non-binding resolution, adopted as part of its debate on a budget plan. The House voted 270-146 last year for repeal of the device tax, a measure that didn’t advance in the Senate.The tax was authorized in 2010 as part of Obama’s larger health-care package. The Joint Committee on Taxation expects the levy to raise about $30 billion over 10 years to help finance the Patient Protection and Affordable Care Act the president pushed into law with a goal of providing health insurance for millions of uninsured Americans.The industry has complained that the tax will cost jobs and impair innovation in the sector.
Revenue Offset
One of the reasons repeal is unlikely soon is that lawmakers disagree on how to offset the revenue the tax will produce. Also, tax legislation must originate in the House, and the Republican-run House doesn’t plan to pass any tax bills until it considers a broader rewrite of the U.S. tax code.The tax has raised almost $200 million in the two months since it took effect.Two leading Senate Democrats, Senate Majority Leader Harry Reid of Nevada and Finance Committee Chairman Max Baucus of Montana, voted against the resolution to eliminate the tax. Still, 34 members of the Senate Democratic caucus joined 45 Republicans in supporting the resolution.
“The importance of this vote cannot be overstated,” said Senator Orrin Hatch, a Utah Republican and ranking minority member of the Finance Committee who offered the resolution. “Democrats and Republicans have come together in recognizing how bad this tax is.”
Industry Reaction
Industry representatives praised the vote as a sign of momentum for repeal of the tax.It shows that “clear majorities in the Senate and the House of Representatives recognize that the medical device tax needs to be repealed so that America’s medical technology community can spur growth and create the great jobs that come along with it,” said Mark Leahey, president of the Medical Device Manufacturers Association.
Defenders of the tax, including Baucus, are skeptical that such overwhelming support would still exist if repeal legislation came to the Senate floor as a proposed law rather than a non-binding measure.“It’s a budget resolution,” Baucus said of the March 21 vote. “We’ll see.”
The White House also discounted the vote’s importance. The “purely symbolic vote has no bearing on the future of the Affordable Care Act and its implementation,” said administration spokesman Brad Carroll.Under both Senate rules and the language of the Hatch amendment, repealing the device tax would require lawmakers to find $30 billion in savings from other programs or through new taxes to replace the lost revenue.Hatch said he intends to continue his push for repeal.
Source:Aaron Lorenzo in Arlington. Editor: Mark Silva.http://www.bloomberg.com/news

(Visited 33 times, 11 visits today)

Filed Under: NEWS Tagged With: 2013

Primary Sidebar

PLATINUM SPONSORS

GOLD SPONSORS

MOST POPULAR POSTS

  • BROCHURES
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • What’s Happening with Globus Medical? Why Has the…
  • Just Reflective, Not Disappointed: Globus Medical’s…
  • (UPDATED 2024): +8 Lumbar Artificial Discs to Know…
  • Stryker’s Spine Business Sale: A Smart Move or a…
  • Stryker’s Spine Exit: What It Means for…
  • Why Didn’t Globus Medical’s Stock Rise After…
  • Globus Medical extends versatility of Advanced…
  • M6 Discontinued: What Are the Alternatives for a…
  • Dispute Over Spinal Implant Royalties Between…
  • Eminent Spine’s 3D Printed Titanium Pedicle Screw…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • (Updated!) 15 Expandable PLIF Cages to Know…!
  • (UPDATED 2024): +108 Stand-Alone Cervical Cages to Know..!
  • Alphatec Today: Where It Stands and Where It’s Heading?
  • What Are the Strategic Reasons Behind Globus…
  • Globus Medical Reports First Quarter 2025 Results
  • Update:Stay Tuned Next Week! Is Globus Medical the…
  • Has Globus Already Surpassed Medtronic in the Spine…
  • LAST 10 VIDEOS PUBLISHED

    1. POWEHI MEDICAL AG: TANTO® Screw
    2. Syntropiq: Taurus TLIF (Short)
    3. LEM Surgical: Dynamis Surgical Robot
    4. Aegis Spine:PathLoc-TA
    5. NGMedical: MOVE®-C Artificial Disc
    6. B.Braun Aesculap: Ennovate® Cervical MIS
    7. Spineart: PERLA® TL Deformity Solutions
    8. NGMedical: MOVE®-C
    9. Normmed Medical: ALIF Peek Cage
    10. PainTEQ: LinQ Sacroiliac

    Recent Comments

    • Sandy on Just Reflective, Not Disappointed: Globus Medical’s Bittersweet Q1 2025
    • SPINEMarketGroup on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Sergio López-Fombona on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Drew on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Ahmed Hassan El-Naggary on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Anonymous on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Email
    • Twitter
    • YouTube

    Subscribe to Our Newsletter!

    Check your inbox or spam folder to confirm your subscription.

    Footer

    • Email
    • Twitter
    • YouTube

    Contact us:

    [email protected] [email protected]

    PRIVATE POLICY

    • Legal Advice
    • Embed Link
    • VIDEOS

    Copyright © 2025 · SPINEMarketGroup

    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    View preferences
    {title} {title} {title}